(Q35531493)

8 August 2017

1 reference

title

Clinical profile of clozapine: adverse reactions and agranulocytosis (English)

1 reference

8 August 2017

J. A. Lieberman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1438605

26 September 2022

A. Z. Safferman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1438605

26 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1438605

26 September 2022

publication date

1 January 1992

1 reference

8 August 2017

Psychiatric Quarterly

1 reference

8 August 2017

63

1 reference

8 August 2017

1

1 reference

8 August 2017

51-70

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01064682

8 August 2017

0 references

cites work

Clozapine-related seizures

1 reference

https://api.crossref.org/works/10.1007%2FBF01064682

Influence of patient-related variables on clozapine plasma levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064682

Effect of adrenergic agents on salivary composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064682

Weight gain among schizophrenic patients treated with clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064682

Polypharmacy in fatal clozapine-associated agranulocytosis

21 January 2018

1 reference

12 December 2020

Apparent neuroleptic malignant syndrome with clozapine and lithium

1 reference

12 December 2020

Clonidine inhibits salivary secretion by activation of postsynaptic ?2-receptors

1 reference

12 December 2020

[Therapeutic method derived from hiberno-therapy in excitation and agitation states]

1 reference

12 December 2020

Update on the clinical efficacy and side effects of clozapine

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

12 December 2020

Adverse drug reactions with clozapine and simultaneous application of benzodiazepines

1 reference

12 December 2020

Clozapine-induced agranulocytosis: a situation report up to August 1976.

1 reference

12 December 2020

Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis.

1 reference

12 December 2020

Antagonism of AP-5-induced sniffing stereotypy links umespirone to atypical antipsychotics

1 reference

12 December 2020

Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis

1 reference

12 December 2020

A retrospective study on the long-term efficacy of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year period.

1 reference

12 December 2020

Effect of phenytoin on plasma clozapine concentrations in two patients

1 reference

12 December 2020

Biochemical and behavioural properties of clozapine

1 reference

12 December 2020

Clozapine withdrawal rebound psychosis

1 reference

12 December 2020

On the possible mechanisms and predictability of clozapine-induced agranulocytosis

1 reference

12 December 2020

Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms

1 reference

12 December 2020

Clozapine. A novel antipsychotic agent

1 reference

12 December 2020

Leponex--associated granulocytopenia: a review of the situation

1 reference

12 December 2020

HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia

1 reference

12 December 2020

Clozapine: plasma levels and prolactin response

1 reference

12 December 2020

Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF)

1 reference

12 December 2020

Clonidine treatment of clozapine-induced hypersalivation

1 reference

12 December 2020

Anticholinergic delirium caused by retreatment with clozapine

1 reference

12 December 2020

Clozapine-induced weight gain

1 reference

12 December 2020

Development of transient obsessive-compulsive symptoms during treatment with clozapine

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report

1 reference

12 December 2020

Eosinophilia with clozapine

1 reference

12 December 2020

Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies

1 reference

12 December 2020

Muscarinic supersensitivity and subsensitivity induced by chronic treatment with atropine and diisopropylfluorophosphate in rat submaxillary glands

1 reference

12 December 2020

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

12 December 2020

Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia.

1 reference

12 December 2020

Supersensitivity and clozapine withdrawal

1 reference

12 December 2020

No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis

1 reference

12 December 2020

Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal

1 reference

12 December 2020

Neuroleptic malignant syndrome after clozapine plus carbamazepine

1 reference

12 December 2020

A case report of cimetidine-induced clozapine toxicity

1 reference

12 December 2020

Clozapine-induced neuroleptic malignant syndrome

1 reference

12 December 2020

Clozapine-associated priapism: a case report

1 reference

12 December 2020

A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.

1 reference

12 December 2020

EEG abnormalities associated with clozapine treatment

1 reference

12 December 2020

Clozapine: guidelines for clinical management

1 reference

12 December 2020

Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia

1 reference

12 December 2020

A case of clozapine-induced neuroleptic malignant syndrome

1 reference

12 December 2020

Clozapine and akathisia

1 reference

12 December 2020

Prevalence and severity of akathisia in patients on clozapine

1 reference

12 December 2020

Dropping objects: possible mild cataplexy associated with clozapine

1 reference

12 December 2020

Clozapine-induced priapism

1 reference

12 December 2020

Clozapine — A Novel Antipsychotic Agent

1 reference

12 December 2020

Possible role of free radical formation in drug-induced agranulocytosis

1 reference

12 December 2020

Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs

1 reference

12 December 2020

Clozapine and jaw dyskinesia: a case report

1 reference

12 December 2020

Clozapine: an atypical antipsychotic agent

1 reference

12 December 2020

Effect of clozapine on human serum prolactin levels

1 reference

12 December 2020

Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain.

1 reference

12 December 2020

Neuroleptic-induced supersensitivity psychosis

1 reference

12 December 2020

Pharmacology of neuroleptics in use in the United States

1 reference

12 December 2020

Agranulocytosis Induced by Certain Phenothiazine Derivatives

1 reference

12 December 2020

Agranulocytosis and phenothiazines

1 reference

12 December 2020

Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic

1 reference

12 December 2020

Early relapse after sudden withdrawal or dose reduction of clozapine

1 reference

12 December 2020

Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.

1 reference

12 December 2020

Clozapine plasma levels and convulsions

1 reference

12 December 2020

Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat.

1 reference

12 December 2020

Clozapine in the treatment of schizophrenic patients: an international multicenter trial.

1 reference

12 December 2020

Nonleukopenic neutropenia in a patient treated with clozapine

1 reference

12 December 2020

Rechallenge in clozapine-induced agranulocytosis

1 reference

12 December 2020

Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat

1 reference

12 December 2020

Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells

1 reference

12 December 2020

Neuroleptic malignant syndrome associated with clozapine use

1 reference

12 December 2020

Mechanisms of clozapine-induced agranulocytosis

1 reference

12 December 2020

Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01064682

1 reference

8 August 2017

1 reference